Pulmonary toxicity associated with spirogermanium.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D005857:Germanium / Q000009:adverse effects*; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000473:pathology; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D013141:Spiro Compounds / Q000009:adverse effects*
D000970:Antineoplastic Agents; D009942:Organometallic Compounds; D013141:Spiro Compounds; D005857:Germanium; C026818:spirogermanium